van Drunen C, Meltzer E O, Bachert C, Bousquet J, Fokkens W J
Department of Otorhinolaryngology, Academic Medical Center, University of Amsterdam, The Netherlands.
Allergy. 2005;60 Suppl 80:5-19. doi: 10.1111/j.1398-9995.2005.00917.x.
Mometasone furoate nasal spray (MFNS; Nasonex, Schering-Plough Corporation, Kenilworth, NJ, USA) is an effective and well-tolerated intranasal corticosteroid approved for the prophylactic treatment of seasonal allergic rhinitis, and the treatment of perennial allergic rhinitis. MFNS is a potent molecule with a rapid onset of action and excellent safety and efficacy profiles. Having recently received approval for the treatment of nasal polyposis, data indicate that MFNS may also be effective in rhinosinusitis.
糠酸莫米松鼻喷雾剂（MFNS；内舒拿，先灵葆雅公司，美国新泽西州肯尼沃斯）是一种有效且耐受性良好的鼻内用皮质类固醇，已获批用于季节性过敏性鼻炎的预防性治疗以及常年性过敏性鼻炎的治疗。MFNS是一种强效分子，起效迅速，安全性和有效性良好。最近已获批用于治疗鼻息肉，数据表明MFNS在鼻窦炎治疗中可能也有效。
